Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
P19429	7137	TNNI3 TNNC1	Lung cancer		Acetylation	N	A2	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Phosphorylation	N	S5	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Phosphorylation	N	S6	
P19429	7137	TNNI3 TNNC1	Pancreatic cancer		Phosphorylation	N	Y29	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Phosphorylation	N	T31	
P19429	7137	TNNI3 TNNC1	Pancreatic cancer		Phosphorylation	N	T31	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Ubiquitination	N	K36	
P19429	7137	TNNI3 TNNC1	Pancreatic cancer		Ubiquitination	N	K36	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Phosphorylation	N	S39	
P19429	7137	TNNI3 TNNC1	Pancreatic cancer		Phosphorylation	N	S39	
P19429	7137	TNNI3 TNNC1	Urinary bladder cancer		Phosphorylation	N	S77	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Phosphorylation	N	Y112	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Ubiquitination	N	K117	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Ubiquitination	N	K120	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Acetylation	N	K140	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Acetylation	N	K140	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Phosphorylation	N	T143	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Phosphorylation	N	T143	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Phosphorylation	N	S150	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Phosphorylation	N	S150	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Ubiquitination	N	K164	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Phosphorylation	N	S166	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Phosphorylation	N	S166	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Ubiquitination	N	K174	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Acetylation	N	K177	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Acetylation	N	K178	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Phosphorylation	N	T181	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Phosphorylation	N	T181	
P19429	7137	TNNI3 TNNC1	Pancreatic cancer		Phosphorylation	N	T181	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Phosphorylation	N	T181	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Ubiquitination	N	K183	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Ubiquitination	N	K183	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Ubiquitination	N	K183	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Ubiquitination	N	K193	
P19429	7137	TNNI3 TNNC1	restrictive cardiomyopathy		Ubiquitination	N	K193	
P19429	7137	TNNI3 TNNC1	Familial hypertrophic cardiomyopathy		Phosphorylation	N	S199	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S5	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Acetylation	N	K35	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K35	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Methylation	N	K35	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Methylation	N	K35	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Ubiquitination	N	K35	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K35	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Ubiquitination	N	K36	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K36	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T41	
Q14315	2318	FLNC ABPL FLN2	Pancreatic adenocarcinoma		Phosphorylation	N	T41	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T43	
Q14315	2318	FLNC ABPL FLN2	Pancreatic adenocarcinoma		Phosphorylation	N	T43	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S78	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	S78	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K80	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S116	
Q14315	2318	FLNC ABPL FLN2	Myopathy		Ubiquitination	N	K189	
Q14315	2318	FLNC ABPL FLN2	Head and neck squamous cell carcinoma		Phosphorylation	N	T423	
Q14315	2318	FLNC ABPL FLN2	Lung squamous cell carcinoma		Phosphorylation	N	T423	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T423	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Ubiquitination	N	K498	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K498	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Ubiquitination	N	K502	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K502	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T512	
Q14315	2318	FLNC ABPL FLN2	Colon adenocarcinoma		Phosphorylation	N	S559	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S559	
Q14315	2318	FLNC ABPL FLN2	Pancreatic adenocarcinoma		Phosphorylation	N	S559	
Q14315	2318	FLNC ABPL FLN2	Thymoma		Phosphorylation	N	S559	
Q14315	2318	FLNC ABPL FLN2	Lung squamous cell carcinoma		Phosphorylation	N	S566	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S566	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Acetylation	N	K621	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K621	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	S625	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S625	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	S625	
Q14315	2318	FLNC ABPL FLN2	Uterus adenocarcinoma		Phosphorylation	N	S625	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K734	
Q14315	2318	FLNC ABPL FLN2	Hepatocellular carcinoma		Phosphorylation	N	Y770	
Q14315	2318	FLNC ABPL FLN2	Kidney renal papillary cell carcinoma		Phosphorylation	N	Y770	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	Y770	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K776	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K776	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Phosphorylation	N	Y833	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	Y833	
Q14315	2318	FLNC ABPL FLN2	Melanoma		Phosphorylation	N	Y833	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	Y833	
Q14315	2318	FLNC ABPL FLN2	Primary dilated cardiomyopathy		Phosphorylation	N	Y833	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	Y833	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	Y833	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	T834	
Q14315	2318	FLNC ABPL FLN2	Melanoma		Phosphorylation	N	T834	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T834	
Q14315	2318	FLNC ABPL FLN2	Primary dilated cardiomyopathy		Phosphorylation	N	T834	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	T834	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	T834	
Q14315	2318	FLNC ABPL FLN2	Colon adenocarcinoma		Ubiquitination	N	K895	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K895	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Phosphorylation	N	S927	
Q14315	2318	FLNC ABPL FLN2	Esophageal adenocarcinoma		Phosphorylation	N	S927	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S927	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S927	
Q14315	2318	FLNC ABPL FLN2	Pancreatic adenocarcinoma		Phosphorylation	N	S927	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S954	
Q14315	2318	FLNC ABPL FLN2	Melanoma		Phosphorylation	N	S954	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S954	
Q14315	2318	FLNC ABPL FLN2	Non-Hodgkin's lymphoma		Phosphorylation	N	S954	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K968	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Colon adenocarcinoma		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Stomach cancer		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Uterine cancer		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Wolff-Parkinson-White pattern		Methylation	N	R1002	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	C	S1005	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	S1005	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S1005	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1005	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	S1005	
Q14315	2318	FLNC ABPL FLN2	Wolff-Parkinson-White pattern		Phosphorylation	N	S1005	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K1014	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K1014	
Q14315	2318	FLNC ABPL FLN2	Ovarian cancer		Phosphorylation	N	S1050	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K1073	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	C	T1079	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T1079	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Phosphorylation	N	S1156	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S1156	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1156	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S1156	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Phosphorylation	N	S1161	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S1161	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1161	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S1161	
Q14315	2318	FLNC ABPL FLN2	Colon adenocarcinoma		Phosphorylation	N	T1240	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T1240	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	T1240	
Q14315	2318	FLNC ABPL FLN2	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K1299	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K1299	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T1305	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1338	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Acetylation	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Acetylation	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Uveal melanoma		Acetylation	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Ubiquitination	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Ubiquitination	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Uveal melanoma		Ubiquitination	N	K1367	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Phosphorylation	N	S1527	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1527	
Q14315	2318	FLNC ABPL FLN2	Ovarian adenocarcinoma		Phosphorylation	N	S1527	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S1527	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Ubiquitination	N	K1532	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Ubiquitination	N	K1532	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Ubiquitination	N	K1532	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K1532	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Ubiquitination	N	K1532	
Q14315	2318	FLNC ABPL FLN2	Cardiomyopathy		Phosphorylation	N	S1624	
Q14315	2318	FLNC ABPL FLN2	Head and neck squamous cell carcinoma		Phosphorylation	N	S1624	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1624	
Q14315	2318	FLNC ABPL FLN2	restrictive cardiomyopathy		Phosphorylation	N	S1624	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1728	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	C	T1799	
Q14315	2318	FLNC ABPL FLN2	Head and neck squamous cell carcinoma		Phosphorylation	N	T1799	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T1799	
Q14315	2318	FLNC ABPL FLN2	Sarcoma		Phosphorylation	N	T1799	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	T1799	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Acetylation	N	K1831	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Acetylation	N	K1831	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K1831	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Acetylation	N	K1831	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1848	
Q14315	2318	FLNC ABPL FLN2	Glioblastoma multiforme		Phosphorylation	N	S1893	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1893	
Q14315	2318	FLNC ABPL FLN2	Glioblastoma multiforme		Phosphorylation	N	S1900	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1900	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S1900	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Phosphorylation	N	S1940	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1940	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Phosphorylation	N	T1943	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T1943	
Q14315	2318	FLNC ABPL FLN2	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S1972	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S1972	
Q14315	2318	FLNC ABPL FLN2	Colon adenocarcinoma		Ubiquitination	N	K1994	
Q14315	2318	FLNC ABPL FLN2	Hepatocellular carcinoma		Ubiquitination	N	K1994	
Q14315	2318	FLNC ABPL FLN2	Melanoma		Ubiquitination	N	K1994	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K1994	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Ubiquitination	N	K1994	
Q14315	2318	FLNC ABPL FLN2	Colon adenocarcinoma		Phosphorylation	N	T2006	
Q14315	2318	FLNC ABPL FLN2	Hepatocellular carcinoma		Phosphorylation	N	T2006	
Q14315	2318	FLNC ABPL FLN2	Kidney renal clear cell carcinoma		Phosphorylation	N	T2006	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T2006	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	T2006	
Q14315	2318	FLNC ABPL FLN2	Kidney renal papillary cell carcinoma		Phosphorylation	N	S2016	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S2016	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2016	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	T2025	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Phosphorylation	N	T2025	
Q14315	2318	FLNC ABPL FLN2	Kidney renal papillary cell carcinoma		Phosphorylation	N	T2025	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	T2025	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T2025	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	S2027	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Phosphorylation	N	S2027	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S2027	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2027	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Acetylation	N	K2030	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Acetylation	N	K2030	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K2030	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Ubiquitination	N	K2030	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Ubiquitination	N	K2030	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K2030	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2042	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S2042	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	C	S2122	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Phosphorylation	N	S2122	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2122	
Q14315	2318	FLNC ABPL FLN2	Brain lower grade glioma		Ubiquitination	N	K2127	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K2127	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Ubiquitination	N	K2127	
Q14315	2318	FLNC ABPL FLN2	Familial hypertrophic cardiomyopathy		Phosphorylation	N	S2137	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	C	S2146	
Q14315	2318	FLNC ABPL FLN2	Familial hypertrophic cardiomyopathy		Phosphorylation	N	S2146	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S2146	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2146	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	S2146	
Q14315	2318	FLNC ABPL FLN2	Uterine corpus endometrial carcinoma		Phosphorylation	N	S2146	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S2233	
Q14315	2318	FLNC ABPL FLN2	Lung squamous cell carcinoma		Phosphorylation	N	S2233	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2233	
Q14315	2318	FLNC ABPL FLN2	Prostate adenocarcinoma		Phosphorylation	N	S2233	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S2233	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	S2233	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S2236	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2236	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	T2238	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T2238	
Q14315	2318	FLNC ABPL FLN2	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S2256	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2256	
Q14315	2318	FLNC ABPL FLN2	Colon adenocarcinoma		Phosphorylation	N	Y2274	
Q14315	2318	FLNC ABPL FLN2	Lung squamous cell carcinoma		Phosphorylation	N	Y2274	
Q14315	2318	FLNC ABPL FLN2	Melanoma		Phosphorylation	N	Y2274	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	Y2274	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	Y2274	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	Y2274	
Q14315	2318	FLNC ABPL FLN2	Hepatocellular carcinoma		Ubiquitination	N	K2291	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Ubiquitination	N	K2291	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K2291	
Q14315	2318	FLNC ABPL FLN2	Rectum adenocarcinoma		Ubiquitination	N	K2291	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Methylation	N	R2293	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Methylation	N	R2293	
Q14315	2318	FLNC ABPL FLN2	Rectum adenocarcinoma		Methylation	N	R2293	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2300	
Q14315	2318	FLNC ABPL FLN2	Pancreatic cancer		Phosphorylation	N	S2300	
Q14315	2318	FLNC ABPL FLN2	Rectum adenocarcinoma		Phosphorylation	N	S2300	
Q14315	2318	FLNC ABPL FLN2	Hypertrophic cardiomyopathy		Methylation	N	K2316	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Methylation	N	K2316	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Methylation	N	K2316	
Q14315	2318	FLNC ABPL FLN2	Hypertrophic cardiomyopathy		Ubiquitination	N	K2316	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K2316	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Ubiquitination	N	K2316	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2395	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S2395	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	T2412	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T2412	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	T2414	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	T2414	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	S2415	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2415	
Q14315	2318	FLNC ABPL FLN2	Adrenocortical carcinoma		Phosphorylation	N	S2490	
Q14315	2318	FLNC ABPL FLN2	Breast invasive carcinoma		Phosphorylation	N	S2490	
Q14315	2318	FLNC ABPL FLN2	Lung squamous cell carcinoma		Phosphorylation	N	S2490	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2490	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2586	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2598	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2617	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	C	S2620	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2620	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	S2620	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2623	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	S2623	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2624	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	S2624	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	Y2625	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	Y2625	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K2630	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Ubiquitination	N	K2630	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2632	
Q14315	2318	FLNC ABPL FLN2	Stomach adenocarcinoma		Phosphorylation	N	S2632	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Ubiquitination	N	K2653	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Ubiquitination	N	K2653	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2655	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	S2655	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	Y2683	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K2685	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Acetylation	N	K2699	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Acetylation	N	K2699	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Acetylation	N	K2699	
Q14315	2318	FLNC ABPL FLN2	Bladder urothelial carcinoma		Phosphorylation	N	Y2704	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	Y2704	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	Y2704	
Q14315	2318	FLNC ABPL FLN2	Skin cutaneous melanoma		Phosphorylation	N	Y2704	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S2714	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2714	
Q14315	2318	FLNC ABPL FLN2	Lung adenocarcinoma		Phosphorylation	N	S2718	
Q14315	2318	FLNC ABPL FLN2	Myofibrillar myopathy		Phosphorylation	N	S2718	
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy	cardiomyocytes	Serine phosphorylation	U	S23	34966794
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy	cardiomyocytes	Serine phosphorylation	U	S24	34966794
P19429	7137	TNNI3 TNNC1	Cardiovascular/heart disease	tumor tissue	Serine phosphorylation	U	S22	23564307
P19429	7137	TNNI3 TNNC1	Cardiovascular/heart disease	tumor tissue	Serine phosphorylation	U	S23	23564307
P19429	7137	TNNI3 TNNC1	Cardiovascular/heart disease	tumor tissue	Serine phosphorylation	D	S43	23564307
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	D	S4	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	D	S5	22972900
P19429	7137	TNNI3 TNNC1	Heart failure		Serine phosphorylation	D	S22	22972900
P19429	7137	TNNI3 TNNC1	Cardiomyopathy		Serine phosphorylation	D	S23	23213108
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	D	S23	22972900
P19429	7137	TNNI3 TNNC1	Cardiomyopathy		Serine phosphorylation	D	S24	23213108
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	D	S25	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Tyrosine phosphorylation	D	Y25	22972900
P19429	7137	TNNI3 TNNC1	Heart failure		Serine phosphorylation	U	S41	22972900
P19429	7137	TNNI3 TNNC1	Heart failure		Serine phosphorylation	U	S43	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	U	S76	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	U	S77	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Threonine phosphorylation	U	T77	22972900
P19429	7137	TNNI3 TNNC1	Heart failure		Serine phosphorylation	U	S142	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	U	S165	22972900
P19429	7137	TNNI3 TNNC1	Heart failure		SUMOylation	U	K177	35633070
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	U	S180	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Threonine phosphorylation	U	T180	22972900
P19429	7137	TNNI3 TNNC1	Dilated cardiomyopathy		Serine phosphorylation	U	S198	22972900
